VRTX Vertex Pharmaceuticals Incorpor | US92532F1003
| Metric | Current | 31.03.2026 | 31.12.2025 | 30.09.2025 |
|---|---|---|---|---|
| Market Cap | 121.156.550.656 | 113.494.373.744,43 | 115.149.457.592,07 | 99.457.559.388,99 |
| Enterprise Value | 115.896.352.768 | 109.987.973.744,43 | 112.095.157.592,07 | 96.352.759.388,99 |
| Trailing P/E | 28,33 | 26,16 | 29,13 | 36,01 |
| Forward P/E | 22,4 | - | - | - |
| Price to Sales | 9,92 | 9,29 | 9,59 | 11,29 |
| Price to Book | 6,27 | 5,86 | 6,17 | 5,74 |
| EV/Revenue | 9,49 | 9 | 9,34 | 10,94 |
| EV/EBITDA | 23,27 | 20,91 | 20,22 | 22,77 |